Literature DB >> 27287642

Diagnostic accuracy of a uniform research case definition for TBM in children: a prospective study.

R S Solomons1, D H Visser2, B J Marais3, J F Schoeman1, A M van Furth2.   

Abstract

BACKGROUND: Bacteriological confirmation of tuberculous meningitis (TBM) is problematic, and rarely guides initial clinical management. A uniform TBM case definition has been proposed for research purposes.
METHODS: We prospectively enrolled patients aged 3 months to 13 years with meningitis confirmed using cerebrospinal fluid analysis at Tygerberg Hospital, Cape Town, South Africa. Criteria that differentiated TBM from other causes were explored and the accuracy of a probable TBM score assessed by comparing bacteriologically confirmed cases to 'non-TBM' controls.
RESULTS: Of 139 meningitis patients, 79 were diagnosed with TBM (35 bacteriologically confirmed), 10 with bacterial meningitis and 50 with viral meningitis. Among those with bacteriologically confirmed TBM, 15 were Mycobacterium tuberculosis culture-positive and 20 were culture-negative but positive on GenoType(®) MTBDRplus or Xpert(®) MTB/RIF; 18 were positive on only a single commercial nucleic acid amplification test. A probable TBM score provided a sensitivity of 74% (95%CI 57-88) and a specificity of 97% (95%CI 86-99) compared to bacteriologically confirmed TBM.
CONCLUSION: A probable TBM score demonstrated excellent specificity compared to bacteriological confirmation. However, 26% of children with TBM would be missed due to the limited accuracy of the case definition. Further prospective testing of an algorithm-based approach to TBM is advisable before recommendation for general clinical practice.

Entities:  

Mesh:

Year:  2016        PMID: 27287642     DOI: 10.5588/ijtld.15.0509

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  10 in total

1.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

Review 2.  Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.

Authors:  Alexander W Kay; Tara Ness; Sabine E Verkuijl; Kerri Viney; Annemieke Brands; Tiziana Masini; Lucia González Fernández; Michael Eisenhut; Anne K Detjen; Anna M Mandalakas; Karen R Steingart; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2022-09-06

Review 3.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

4.  Case definition terminology for paratuberculosis (Johne's disease).

Authors:  R J Whittington; D J Begg; K de Silva; A C Purdie; N K Dhand; K M Plain
Journal:  BMC Vet Res       Date:  2017-11-09       Impact factor: 2.741

5.  Pooled analysis of the Xpert MTB/RIF assay for diagnosing tuberculous meningitis.

Authors:  Yuan-Zhi Chen; Li-Chang Sun; Yao-Hong Wen; Zhong-Wei Li; Shu-Jin Fan; Hong-Kun Tan; Min Qiu; Zhi-Yong Pan; Qin Li; Yan-Zhen Zhao; Zhen-Xing Li; Xu-Guang Guo
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

Review 6.  Diagnostic Challenges in Childhood Pulmonary Tuberculosis-Optimizing the Clinical Approach.

Authors:  Kenneth S Gunasekera; Bryan Vonasek; Jacquie Oliwa; Rina Triasih; Christina Lancioni; Stephen M Graham; James A Seddon; Ben J Marais
Journal:  Pathogens       Date:  2022-03-23

7.  Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.

Authors:  Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27

8.  Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study.

Authors:  Robindra Basu Roy; Stephanie Thee; Daniel Blázquez-Gamero; Lola Falcón-Neyra; Olaf Neth; Antoni Noguera-Julian; Cristina Lillo; Luisa Galli; Elisabetta Venturini; Danilo Buonsenso; Florian Götzinger; Nuria Martinez-Alier; Svetlana Velizarova; Folke Brinkmann; Steven B Welch; Maria Tsolia; Begoña Santiago-Garcia; Renate Krüger; Marc Tebruegge
Journal:  Eur Respir J       Date:  2020-07-02       Impact factor: 16.671

Review 9.  Tuberculous meningitis in children: Clinical management & outcome.

Authors:  Bella Devaleenal Daniel; G Angeline Grace; Mohan Natrajan
Journal:  Indian J Med Res       Date:  2019-08       Impact factor: 2.375

Review 10.  Tuberculous Meningitis in Children: Reducing the Burden of Death and Disability.

Authors:  Julie Huynh; Yara-Natalie Abo; Karen du Preez; Regan Solomons; Kelly E Dooley; James A Seddon
Journal:  Pathogens       Date:  2021-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.